| 32391125 | Correction: Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model. | Oncotarget | 2020 |
| 29750868 | BRCA Status Does Not Predict Synergism of a Carboplatin and Olaparib Combination in High-Grade Serous Ovarian Cancer Cell Lines. | Mol Pharm | 2018 |
| 29152107 | Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model. | Oncotarget | 2017 |
| 26876200 | Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway. | Oncogene | 2016 |
| 26005866 | Spatial genomic heterogeneity within localized, multifocal prostate cancer. | Nat Genet | 2015 |
| 26277432 | In vivo studies of the PARP inhibitor, AZD-2281, in combination with fractionated radiotherapy: An exploration of the therapeutic ratio. | Radiother Oncol | 2015 |
| 25361396 | Hypoxia and cellular localization influence the radiosensitizing effect of gold nanoparticles (AuNPs) in breast cancer cells. | Radiat Res | 2014 |
| 25415046 | NBN gain is predictive for adverse outcome following image-guided radiotherapy for localized prostate cancer. | Oncotarget | 2014 |
| 25456371 | Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study. | Lancet Oncol | 2014 |
| 23640976 | 4FISH-IF, a four-color dual-gene FISH combined with p63 immunofluorescence to evaluate NKX3.1 and MYC status in prostate cancer. | J Histochem Cytochem | 2013 |
| 22048240 | NKX3.1 haploinsufficiency is prognostic for prostate cancer relapse following surgery or image-guided radiotherapy. | Clin Cancer Res | 2012 |
| 23041623 | Protease nexin 1 inhibits hedgehog signaling in prostate adenocarcinoma. | J Clin Invest | 2012 |
| 22213075 | Allelic loss of the loci containing the androgen synthesis gene, StAR, is prognostic for relapse in intermediate-risk prostate cancer. | Prostate | 2012 |
| 20235236 | The role of SMAD4 in human embryonic stem cell self-renewal and stem cell fate. | Stem Cells | 2010 |
| 20590366 | Array CGH as a potential predictor of radiocurability in intermediate risk prostate cancer. | Acta Oncol | 2010 |
| 20619004 | Tumor senescence and radioresistant tumor-initiating cells (TICs): let sleeping dogs lie! | Breast Cancer Res | 2010 |
| 19350677 | Specific knockdown of OCT4 in human embryonic stem cells by inducible short hairpin RNA interference. | Stem Cells | 2009 |
| 15489896 | Defining minimum genomic regions of imbalance involved in testicular germ cell tumors of adolescents and adults through genome wide microarray analysis of cDNA clones. | Oncogene | 2004 |
| 12752258 | Role of gain of 12p in germ cell tumour development. | APMIS | 2003 |
| 12941700 | HS5 of the human beta-globin locus control region: a developmental stage-specific border in erythroid cells. | EMBO J | 2003 |
| 14576833 | 12p-amplicon structure analysis in testicular germ cell tumors of adolescents and adults by array CGH. | Oncogene | 2003 |
| 12660824 | Expression profile of genes from 12p in testicular germ cell tumors of adolescents and adults associated with i(12p) and amplification at 12p11.2-p12.1. | Oncogene | 2003 |
| 11912161 | Coamplification of DAD-R, SOX5, and EKI1 in human testicular seminomas, with specific overexpression of DAD-R, correlates with reduced levels of apoptosis and earlier clinical manifestation. | Cancer Res | 2002 |
| 11060036 | Erythroid overexpression of C/EBPgamma in transgenic mice affects gamma-globin expression and fetal liver erythropoiesis. | EMBO J | 2000 |
| 11021820 | Restricted 12p amplification and RAS mutation in human germ cell tumors of the adult testis. | Am J Pathol | 2000 |
| 8756670 | Rat embryo fibroblasts immortalized with simian virus 40 large T antigen undergo senescence upon its inactivation. | Mol Cell Biol | 1996 |
| 9012519 | The human beta-globin locus control region confers an early embryonic erythroid-specific expression pattern to a basic promoter driving the bacterial lacZ gene. | Development | 1996 |